Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110498 · ClinicalTrials.gov registry record
Early Detection of Pancreatic Cystic Neoplasms
A clinical trial of Intraductal Papillary Mucinous Neoplasm and Pancreatic Cysts, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT02110498 is a study of Intraductal Papillary Mucinous Neoplasm and Pancreatic Cysts that has completed, run by Johns Hopkins University. The registered enrollment target is 3,000 participants, above the 1,531-participant average among 4 other Intraductal Papillary Mucinous Neoplasm trials with a reported enrollment target (96% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02110498, a study of Intraductal Papillary Mucinous Neoplasm and Pancreatic Cysts, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to learn more about pancreatic cysts. The tests that are currently available are imperfect at determining exactly what type of pancreatic cyst a person has, which cysts contain cancer, or what the risk is of developing cancer in the future. The aim of this study is to use a combination of clinical, imaging, cyst fluid analysis, and molecular markers to try to help develop better tools to answer these questions.
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2014-03 |
| Est. Completion | 2025-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02110498
The ClinicalTrials.gov registry entry for NCT02110498 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,531-participant average among 4 other Intraductal Papillary Mucinous Neoplasm trials with a reported enrollment target (96% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Intraductal Papillary Mucinous Neoplasm appearing as the primary indexed condition, and to 0 interventions.
NCT02110498 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02110498 about?
NCT02110498 is a clinical study titled "Early Detection of Pancreatic Cystic Neoplasms". This research is being done to learn more about pancreatic cysts. The tests that are currently available are imperfect at determining exactly what type of pancreatic cyst a person has, which cysts contain cancer, or what the risk is of developing cancer in the future. The aim of this study is to use...
What is the current status of trial NCT02110498?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2014-03. Estimated completion is 2025-03.
What conditions does trial NCT02110498 study?
This clinical trial studies the following conditions: Intraductal Papillary Mucinous Neoplasm, Pancreatic Cysts, Pancreatic Mucinous Cystic Neoplasm, Cystic, Mucinous and/or Serous Neoplasm, Solid Pseudopapillary Tumour of the Pancreas.
Who is sponsoring clinical trial NCT02110498?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02110498 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraductal Papillary Mucinous Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.